Loading data for CVRX — first visit, this takes a few seconds.
CVRx Inc. (CVRX)
NasdaqGS: CVRX
· Real-Time Price · USD
3.15
+0.31 (10.92%)
At close: Aug 25, 2026, 7:28 PM
The price, the headline numbers and the latest news, in one place.
CVRx Inc. (CVRX) Stock Price, Analysis & Data
10.92% (1D)
No data available
| Bid | 2.24 |
| Market Cap | 89.38M |
| Revenue (ttm) | 61.19M |
| Net Income (ttm) | -51.97M |
| 0.82 | |
| -1.97 | |
| n/a | |
| -1.79 | |
| P/B (ttm) | 4.48 |
| P/S (ttm) | 1.46 |
| Earnings Date | Nov 5, 2026 |
| Ask | 3.84 |
| Volume | 1,615,698 |
| Avg. Volume (20D) | 679,990 |
| Open | 2.99 |
| Previous Close | 2.84 |
| Day's Range | 2.86 - 3.29 |
| 52-Week Range | 2.20 - 11.30 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About CVRX
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased baroreceptor signaling, and provides baroreflex act...
Industry Medical Devices
Sector Healthcare
IPO Date Jun 30, 2021
Employees 223
Stock Exchange NasdaqGS
Ticker Symbol CVRX
Website https://www.barostim.com
Financial Performance
In 2025, CVRx's revenue was 56.65M, an increase of 10.45% compared to the previous year's 51.29M. Earnings were -53.31M, a decrease of -11.1%.
Financial StatementsEarnings Surprise
CVRx has released their quarterly earnings on Aug 6, 2026:
- Revenue of $15.71M misses estimates by $0, with 15.57% YoY growth.
- EPS of -0.53 misses estimates by -0.01, with 7.02% YoY growth.
CVRx Inc. is scheduled to release its earnings on Nov 5, 2026, during market hours.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2